Craig Venter (R) speaks with Eric Topol, Scripps Health chief academic officer and director of the Scripps Translational Science Institute, during a symposium on "The Future of Genomic Medicine" at ... more 
Craig Venter (R) speaks with Eric Topol, Scripps Health chief academic officer and director of the Scripps Translational Science Institute, during a symposium on "The Future of Genomic Medicine" at Scripps Seaside Forum in La Jolla, California March 6, 2014. Earlier this week, Venter announced formation of a new company, Human Longevity Inc, to undertake a massive project: sequencing 40,000 human genomes a year in a search for new therapies to preserve health and fight off diseases, including cancer, heart disease and Alzheimer's. To match Analysis GENOMICS-FUTURE/ REUTERS/Sam Hodgson (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY) less 
1 / 29
Reuters | Photo By SAM HODGSON / REUTERS
Thu, Mar 6, 2014 4:57 PM EST